Medication info
Crestt Tablet 10/20 mg (Ezetimibe, Rosuvastatin)

Crestt Tablet 10/20 mg (Ezetimibe, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201506787 · Approved 2015.09.24 · Insurance code 641606140

Summary

Main use
Improvement of mixed dyslipidemia and primary hypercholesterolemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of mixed dyslipidemia and primary hypercholesterolemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia.
View approved original text

This medication is used to improve cholesterol and related lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It specifically lowers total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol levels, which helps vascular health. This medication is used alongside a suitable diet and is effective when other non-drug treatments are insufficiently responsive. It is also used cautiously in patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia. It is important to identify and manage secondary causes of dyslipidemia before starting this medication. This medication effectively reduces the risk of cardiovascular disease.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This medication carries a risk of rhabdomyolysis, which can cause muscle tissue damage leading to acute kidney failure. Caution should be taken, and temporary discontinuation may be necessary, especially in patients with severe symptoms of myopathy or risk factors such as severe infections, hypotension, major surgery, trauma, metabolic and electrolyte disorders. Patients with a history of allergic reactions to this medication’s active ingredients or components, patients with active liver disease, those with muscle disorders, patients using specific immunosuppressants, patients with severe renal impairment, pregnant or potentially pregnant women, and breastfeeding mothers should not take this medication. Moderate renal impairment, hypothyroidism, a history of genetic muscle disease, a history of muscle toxicity from other statins or fibrate medications, alcohol dependence, and Asian patients are among those who should also take this medication with caution. This medication contains lactose and should not be administered to patients with lactose intolerance. Patients with a history of alcoholism or liver disease should be carefully monitored for potential liver function deterioration. It is not recommended for patients with severe liver dysfunction. If muscle-related adverse effects such as muscle pain, myopathy, or rhabdomyolysis occur, patients should immediately inform their physician and undergo examination, and in severe cases, discontinuation of the medication should be considered. Liver function tests should be conducted at baseline, and if liver enzyme levels rise abnormally during treatment, dosage adjustments or discontinuation of the medication should be evaluated. Blood sugar levels may increase during treatment with this medication, but it is considered that the cardiovascular risk reduction benefit outweighs the risk of increased blood sugar levels. There may be interactions when taking this medication with other drugs, especially when used with anticoagulants, fibrate class drugs, certain antibiotics, and antifungals, so caution is required in these combinations. Pregnant or breastfeeding women should not take this medication due to risks to the fetus and infant, and women of childbearing potential should employ appropriate contraception while on this medication. Special caution is required when administering to children and the elderly, and safety for children has not been established. In cases of overdose, treatment should be symptomatic, and liver and muscle enzyme tests should be conducted appropriately. This medication should be kept out of reach of children and should not be transferred to another container.

Side effects

pharyngitis, dyspepsia, increased ALT, edema, myalgia, headache, acute pyelonephritis, dry mouth, increased liver enzymes, abnormal liver function test, increased serum lactate dehydrogenase, pruritus, increased AST, elevated blood sugar, increased serum CPK, chest discomfort, dizziness, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, depression, bronchitis, rhinitis, cystitis, onychomycosis, cellulitis, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disturbance, pelvic pain, breast cyst, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, angioedema, vascular swelling, hypersensitivity reaction, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, insomnia, nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, cognitive impairment, memory decline, forgetfulness, amnesia, memory disorder, confusion, myasthenia gravis, ocular myasthenia gravis, chest pain, cough, myalgia, increased CK, constipation, increased AST, weakness, arthralgia, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine, fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, erythema multiforme, cholelithiasis, cholecystitis, cholecystitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1°C and 30°C. Proper storage can ensure the medication's effectiveness.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.